Global Transplantation Market 2017-2021
Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
Technavio’s analysts forecast the global transplantation market to grow at a CAGR of 9.76% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global transplantation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products, which are used for treatment purposes.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Transplantation Market 2017-2021
Technavio recognizes the following companies as the key players in the global transplantation market: Bio-Rad Laboratories, Illumina, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Abbott Laboratories, Acelity, Avioq, AxoGen, BD, BioLifeSolutions, CARMAT, CareDx, Chronix Biomedical, Dr. Franz Köhler Chemie, GenDx, HistoGenetics, Luminex, Miromatrix Medical, Medipex, Nano Dimension, Organovo, Ortho Clinical Diagnostics, Oxford Immunotec, Pacific Biosciences of California, Pandorum Technologies, Qiagen, Roche , Siemens Healthineers, SynCardia, Transplant Biomedicals, and XVIVO Perfusion.
Commenting on the report, an analyst from Technavio’s team said: “One trend in market is emergence of 3D bioprinting. 3D bioprinting is a process used to develop tissues in various formats, from micro-scale tissue to standard multi-well tissue, where cell functions and viabilities are preserved within the printed construct. It provides information about cell concentration and diameter of the printed cells. The 3D bioprinters provides information about the cells in kidney, liver, and heart, its metabolic functions.”
According to the report, one driver in market is increased incidence of organ failure. The demand for tissue and organs such as bone marrow, heart, liver, kidney, and lungs is very high worldwide. Increased alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. According to a combined study conducted by the Department of Internal Medicine, Division of Hepatology, Loyola University Medical Center; Department of Preventive Health Sciences, Stritch School of Medicine, Loyola University Chicago; and Division of Gastroenterology and Hepatology, University of Michigan Health System, US in 2015, liver cirrhosis is one of the major factors of death in the US. The study found that during 1999-2010 around 633,323 adults were diagnosed with liver cirrhosis. Such statistics indicate the rising demand for liver transplantation as a part of treatment, and accounts for the increased number of liver transplantation cases in the US.
Further, the report states that one challenges in market is organ shortage and limited technical expertise. Shortage of organs for transplantation is one of the major challenges in the market. For organ transplantation, patients need to register themselves with organ and transplantation organizations, which are either government institutes or private entities registered with the government. Registration helps the government to track the number of people waiting for transplants and the number of donors. According to Department of Health and Human Services, Health Resources and Services Administration's Healthcare Systems Bureau, the US, in 2016, around two out of three people aged above 50 years were waiting for transplantation. Shortage of organs can lead to the death of patients, which is impacting the market growth negatively.
Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific, Abbott Laboratories, Acelity, Avioq, AxoGen, BD, BioLifeSolutions, CARMAT, CareDx, Chronix Biomedical, Dr. Franz Köhler Chemie, GenDx, HistoGenetics, Luminex, Miromatrix Medical, Medipex, Nano Dimension, Organovo, Ortho Clinical Diagnostics, Oxford Immunotec, Pacific Biosciences of California, Pandorum Technologies, Qiagen, Roche , Siemens Healthineers, SynCardia, Transplant Biomedicals, and XVIVO Perfusion.